Legend Biotech(LEGN),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

LEGN Legend Biotech

Trading 01-21 12:56:00 EST

20.13

-3.29

-14.05%

High22.04	Low20.10	Vol4.43M
Open21.98	D1 Closing23.42	Amplitude8.28%
Mkt Cap3.72B	Tradable Cap1.64B	Total Shares184.69M
T/O92.18M	T/O Rate5.44%	Tradable Shares81.38M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"LEGN","market":"US","secType":"STK","nameCN":"Legend Biotech","latestPrice":20.13,"timestamp":1769018153801,"preClose":23.42,"halted":0,"volume":4429314,"delay":0,"changeRate":-0.14047822374039293,"floatShares":81382003,"shares":184689564,"eps":-1.30264,"marketStatus":"Trading","change":-3.29,"latestTime":"01-21 12:56:00 EST","open":21.98,"high":22.04,"low":20.1,"amount":92181540.885858,"amplitude":0.082835,"askPrice":20.14,"askSize":348,"bidPrice":20.12,"bidSize":230,"shortable":0,"etf":0,"ttmEps":-1.30264,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1769029200000},"marketStatusCode":2,"adr":0,"adrRate":2,"listingDate":1591329600000,"exchange":"NASDAQ","adjPreClose":23.42,"preHourTrading":{"tag":"盘前","latestPrice":21.98,"preClose":23.42,"latestTime":"09:29 EST","volume":38803,"amount":860159.992474,"timestamp":1769005799999,"change":-1.44,"changeRate":-0.061486,"amplitude":0.07231},"postHourTrading":{"tag":"盘后","latestPrice":23.3,"preClose":23.42,"latestTime":"19:50 EST","volume":21553,"amount":504615.5514,"timestamp":1768956626086,"change":-0.12,"changeRate":-0.005124,"amplitude":0.011102},"volumeRatio":3.224713,"impliedVol":0.5651,"impliedVolPercentile":0.5498},"requestUrl":"/m/hq/s/LEGN/tweets","defaultTab":"tweets","newsList":[{"id":"2605248505","title":"Legend Biotech falls -10.5%","url":"https://stock-news.laohu8.com/highlight/detail?id=2605248505","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605248505?lang=en_us&edition=fundamental","pubTime":"2026-01-21 23:06","pubTimestamp":1769007974,"startTime":"0","endTime":"0","summary":"Legend Biotech (LEGN) is down -10.5%, or -$2.46 to $20.96. Published first on TheFly – the ultimate source for real-time, market-moving breaking fi...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/legend-biotech-falls-10-5-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/legend-biotech-falls-10-5-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LABU","BK4585","BK4588","BK4139","BK4505","LEGN"],"gpt_icon":0},{"id":"2605710009","title":"Analysts Offer Insights on Healthcare Companies: Corvus Pharmaceuticals (CRVS) and Legend Biotech (LEGN)","url":"https://stock-news.laohu8.com/highlight/detail?id=2605710009","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605710009?lang=en_us&edition=fundamental","pubTime":"2026-01-21 21:42","pubTimestamp":1769002960,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Corvus Pharmaceuticals (CRVS – Research Report) and ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-corvus-pharmaceuticals-crvs-and-legend-biotech-legn-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-corvus-pharmaceuticals-crvs-and-legend-biotech-legn-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LEGN","BK4581","LU0128526141.USD","LU0029874061.USD","BK4568","XBI","BK4505","BK4137","BK4585","BK4588","CRVS","LABU","BK4139","XLV","HCSG"],"gpt_icon":0},{"id":"2605102175","title":"Legend Biotech Highlights New CARVYKTI Clinical Data at 2026 Tandem Meetings","url":"https://stock-news.laohu8.com/highlight/detail?id=2605102175","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605102175?lang=en_us&edition=fundamental","pubTime":"2026-01-21 21:00","pubTimestamp":1769000446,"startTime":"0","endTime":"0","summary":"Legend Biotech Corporation announced that it will present six poster presentations featuring new data on CARVYKTI  at the 2026 Tandem Meetings of ASTCT, scheduled for February 4-7, 2026. The presentations will highlight CARVYKTI efficacy, safety, and real-world outcomes across various CARTITUDE trials and analyses. Topics include quality-adjusted survival analysis of neurologic events, effectiveness of bridging therapy, manufacturing outcomes, and long-term progression-free survival benefit in multiple myeloma. The results will be presented at the conference and have not yet been publicly presented.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Legend Biotech Corporation published the original content used to generate this news brief ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260121:nNDL2q15S9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LEGN","BK4112","IE00BGHQF748.EUR","IE00B3QW5Z07.USD","BK4139","NDAQ","SG9999014039.USD","SG9999014021.USD","IE00B64PRP62.GBP","LU2210150020.SGD","BK4585","LU0314104364.USD","IE00BKPKM429.USD","LU2095319765.USD","BK4505","LU2210149790.SGD","SG9999014013.SGD","BK4588","SG9999014005.SGD"],"gpt_icon":0},{"id":"2605104626","title":"Legend Biotech Reports Preliminary $555 Million CARVYKTI Sales for Q4 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2605104626","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605104626?lang=en_us&edition=fundamental","pubTime":"2026-01-21 20:30","pubTimestamp":1768998651,"startTime":"0","endTime":"0","summary":"Legend Biotech Corporation announced preliminary business results for the quarter ended December 31, 2025. According to information provided by Janssen, CARVYKTI generated approximately $555 million in net trade sales during the quarter. The sales figure is based on data available to Legend Biotech as of the date of the announcement and has not been independently verified by the company. The determination of revenue or gross profit to be recorded in Legend Biotech's consolidated financial statements is subject to completion by management and review by independent auditors. The company noted that actual results may differ materially from forward-looking statements due to various factors, including regulatory actions, clinical trial outcomes, and market competition.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes o","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260121:nNDL29JGqC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4505","BK4588","BK4585","LEGN"],"gpt_icon":0},{"id":"2605148116","title":"Legend Biotech Is Maintained at Outperform by RBC Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2605148116","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605148116?lang=en_us&edition=fundamental","pubTime":"2026-01-21 01:44","pubTimestamp":1768931040,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/LEGN/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  January 20, 2026 12:44 ET (17:44 GMT)","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LEGN","LABU"],"gpt_icon":0},{"id":"2605411083","title":"FDA draft guidance favorable for Legend Biotech, says RBC Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2605411083","media":"TIPRANKS","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605411083?lang=en_us&edition=fundamental","pubTime":"2026-01-21 00:25","pubTimestamp":1768926314,"startTime":"0","endTime":"0","summary":"The FDA issued draft guidance supporting the use of minimal residual disease negativity and complete response rate as accelerated approval endpoint...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/fda-draft-guidance-favorable-for-legend-biotech-says-rbc-capital-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/fda-draft-guidance-favorable-for-legend-biotech-says-rbc-capital-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4505","LABU","BK4585","BK4588","LU0708994859.HKD","LEGN","LU0128525929.USD","LU1267930573.SGD","BK4139","LU0029864427.USD","BK4207","LU0310800379.SGD"],"gpt_icon":0},{"id":"2604305185","title":"U.S. RESEARCH ROUNDUP-Boeing, Goldman Sachs, PNC Financial Services","url":"https://stock-news.laohu8.com/highlight/detail?id=2604305185","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2604305185?lang=en_us&edition=fundamental","pubTime":"2026-01-19 15:37","pubTimestamp":1768808266,"startTime":"0","endTime":"0","summary":"U.S. RESEARCH ROUNDUP-Boeing, Goldman Sachs, PNC Financial ServicesJan 19 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, includin","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260119:nL8N3YK08N:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RIOT","EL","GS","AEM","PG","LU0234572021.USD","LU0310800965.SGD","PNC","COTY","BK4161","HSY","LU1804176565.USD","PEP","LU0321505439.SGD","HLIO","CC","LU0094547139.USD","LU1430594728.SGD","LEGN","B","MTB","LU0048573561.USD","OTLY","LU1023059493.AUD","NEM","WPM","CLX","SCI","LU0266013472.USD","KMB","IE00B3T34201.USD","CPB","LU1244550494.USD","IE00BFXG1179.USD","IFF","LU0306807586.USD","LU0612318971.USD","LU2552382132.HKD","TAP","LU0963586101.USD","LU0106831901.USD","CL","BRBR","IE00BWXC8680.SGD","LU2308191902.HKD","OLPX","ENR","BA","RGLD","DAL"],"gpt_icon":0},{"id":"2603497602","title":"Piper Sandler Remains a Buy on Legend Biotech (LEGN)","url":"https://stock-news.laohu8.com/highlight/detail?id=2603497602","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603497602?lang=en_us&edition=fundamental","pubTime":"2026-01-15 20:08","pubTimestamp":1768478907,"startTime":"0","endTime":"0","summary":"In a report released today, Edward Tenthoff from Piper Sandler reiterated a Buy rating on Legend Biotech, with a price target of $78.00. Tenthoff c...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/piper-sandler-remains-a-buy-on-legend-biotech-legn-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/piper-sandler-remains-a-buy-on-legend-biotech-legn-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","BK4139","BK4588","BK4505","LEGN"],"gpt_icon":0},{"id":"2603422446","title":"Legend Biotech Signals 2026 Profitability Push and CARVYKTI Expansion in Updated J.P. Morgan Presentation","url":"https://stock-news.laohu8.com/highlight/detail?id=2603422446","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603422446?lang=en_us&edition=fundamental","pubTime":"2026-01-15 05:30","pubTimestamp":1768426256,"startTime":"0","endTime":"0","summary":"Legend Biotech ( ($LEGN) ) has issued an update. On January 14, 2026, Legend Biotech updated its corporate presentation at the 44th Annual J.P. Mor...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/legend-biotech-signals-2026-profitability-push-and-carvykti-expansion-in-updated-j-p-morgan-presentation?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/legend-biotech-signals-2026-profitability-push-and-carvykti-expansion-in-updated-j-p-morgan-presentation?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0320765646.SGD","LU1244550221.USD","LU0006306889.USD","LU1732799900.SGD","LU1363072403.SGD","LU1989772923.USD","LU1732800096.USD","LU0158827948.USD","LU1791710582.SGD","LU0795875086.SGD","BK4505","IE00BKVL7J92.USD","BK4588","LU0106261372.USD","LU0267386448.USD","LU0912757837.SGD","LU1244550577.SGD","LU1791710400.SGD","LU1162221912.USD","LEGN","LU0106831901.USD","LU0557290698.USD","LU0098860793.USD","BK4534","LU1074936037.SGD","BK4139","LU1989772840.SGD","BK4127","LU1668664300.SGD","LU2023251221.USD","BK4504","IE00BZ1G4Q59.USD","LU0882574139.USD","LU0234570918.USD","LU2347655156.SGD","LU1244550494.USD","LU0971096721.USD","LU1548497426.USD","BK4585","LU2133065610.SGD","BK4516","LU1720051108.HKD","LU0314104364.USD","LU2111349929.HKD","LU0795875169.SGD","LU2271345857.HKD","LU2357305700.SGD","BK4581","LU0225283273.USD","LU2089284900.SGD"],"gpt_icon":0},{"id":"2603977976","title":"Legend Biotech (LEGN) Is Up 7.6% After Scaling CARVYKTI Output And Targeting 2026 Profitability - Has The Bull Case Changed?","url":"https://stock-news.laohu8.com/highlight/detail?id=2603977976","media":"Simply Wall St.","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603977976?lang=en_us&edition=fundamental","pubTime":"2026-01-14 15:18","pubTimestamp":1768375138,"startTime":"0","endTime":"0","summary":"Legend Biotech recently reported that more than 10,000 patients have now been treated with its CARVYKTI therapy and that it has expanded production with what it describes as the largest cell therapy manufacturing facility in the U.S., while guiding that it aims to reach profitability in 2026.\nBeyond the headline numbers, the combination of scaled CARVYKTI manufacturing and progress on its in vivo cell therapy pipeline suggests a company increasingly geared toward broader clinical use and...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-legn/legend-biotech/news/legend-biotech-legn-is-up-76-after-scaling-carvykti-output-a","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-legn/legend-biotech/news/legend-biotech-legn-is-up-76-after-scaling-carvykti-output-a","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4505","BK4585","BK4588","BK4139","LEGN"],"gpt_icon":0},{"id":"2602351702","title":"Legend Biotech Showcases Growth and Pipeline Progress at J.P. Morgan Healthcare Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2602351702","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602351702?lang=en_us&edition=fundamental","pubTime":"2026-01-12 21:00","pubTimestamp":1768222849,"startTime":"0","endTime":"0","summary":"Legend Biotech Corporation participated in the 44th Annual J.P. Morgan Healthcare Conference, where CEO Dr. Ying Huang presented the company’s recent business updates and strategic priorities for 2026. Highlights included surpassing 10,000 patients treated with CARVYKTI, expanding manufacturing capacity at the Raritan facility, and outlining plans for profitability in 2026. The company also discussed advancements in its in vivo CAR-T pipeline and ongoing global expansion efforts, with CARVYKTI now available at over 279 sites in 14 markets. The presentation was webcast live for investors and interested parties.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Legend Biotech Corporation published the original content used to generate this ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260112:nNDL4G20F6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2210150020.SGD","SG9999014013.SGD","LU2210149790.SGD","LU2095319765.USD","SG9999014005.SGD","BK4112","IE00BGHQF748.EUR","BK4588","BK4505","IE00B64PRP62.GBP","SG9999014021.USD","NDAQ","SG9999014039.USD","IE00BKPKM429.USD","BK4139","LEGN","IE00B3QW5Z07.USD","LU0314104364.USD","BK4585"],"gpt_icon":0},{"id":"2602177445","title":"Legend Biotech Highlights Recent Business Updates at 44TH Annual J.p. Morgan Healthcare Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2602177445","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602177445?lang=en_us&edition=fundamental","pubTime":"2026-01-12 21:00","pubTimestamp":1768222809,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260112:nTUA1Z49QP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4585","BK4505","LEGN","BK4588","BK4139"],"gpt_icon":0},{"id":"1165322440","title":"Former Legend Biotech VP Pan Qi Joins Shuimu Molecular as Chief Biomedical Scientist","url":"https://stock-news.laohu8.com/highlight/detail?id=1165322440","media":"Deep News","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1165322440?lang=en_us&edition=fundamental","pubTime":"2026-01-09 08:40","pubTimestamp":1767919234,"startTime":"0","endTime":"0","summary":"It has been exclusively learned that Pan Qi, the former R&D Vice President of Legend Biotech, has joined \"Shuimu Molecular,\" an AI-driven biomedical company incubated by Tsinghua University's...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","BK4505","161726","BK4588","LEGN","BK4139","399441"],"gpt_icon":0},{"id":"2601677365","title":"Legend Biotech Corp : RBC Cuts Target Price to $66 From $74","url":"https://stock-news.laohu8.com/highlight/detail?id=2601677365","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601677365?lang=en_us&edition=fundamental","pubTime":"2026-01-08 19:31","pubTimestamp":1767871889,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260108:nFWN3Y90KY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LEGN","BK4139","BK4505","BK4588","BK4585"],"gpt_icon":0},{"id":"2601086568","title":"Oppenheimer Initiates Legend Biotech at Outperform With $75 Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2601086568","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601086568?lang=en_us&edition=fundamental","pubTime":"2026-01-07 20:30","pubTimestamp":1767789027,"startTime":"0","endTime":"0","summary":"Legend Biotech (LEGN) has an average rating of buy and mean price target of $70.61, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major bank","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["OPY","LEGN"],"gpt_icon":0},{"id":"1197419829","title":"Legend Biotech's Stock Plummets 50% in Half a Year: A Valuation Trap or a Golden Opportunity?","url":"https://stock-news.laohu8.com/highlight/detail?id=1197419829","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1197419829?lang=en_us&edition=fundamental","pubTime":"2026-01-07 17:55","pubTimestamp":1767779724,"startTime":"0","endTime":"0","summary":"On January 6, the stock price of Legend Biotech (LEGN.US) experienced a sharp decline within the first five minutes of trading. Although a subsequent strong rebound pushed the intraday gain to over...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["518880","GCmain","SGCmain","GLD","BK4139","DUST","MGCmain","BK4585","BK4505","IAU","LEGN","SGUmain","159831","BK4588","QOmain","NUGT","159934","GDX","1OZmain"],"gpt_icon":1},{"id":"2592329919","title":"Legend Biotech Is Maintained at Overweight by Cantor Fitzgerald","url":"https://stock-news.laohu8.com/highlight/detail?id=2592329919","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592329919?lang=en_us&edition=fundamental","pubTime":"2025-12-17 23:04","pubTimestamp":1765983840,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/LEGN/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  December 17, 2025 10:04 ET (15:04 GMT)","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LEGN"],"gpt_icon":0},{"id":"2591683289","title":"Legend Biotech Is Maintained at Overweight by Morgan Stanley","url":"https://stock-news.laohu8.com/highlight/detail?id=2591683289","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2591683289?lang=en_us&edition=fundamental","pubTime":"2025-12-13 01:26","pubTimestamp":1765560360,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/LEGN/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  December 12, 2025 12:26 ET (17:26 GMT)","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LEGN"],"gpt_icon":0},{"id":"2590953199","title":"Legend Biotech's Stock Weakness After Rival Treatment Update 'Overdone,' RBC Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2590953199","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590953199?lang=en_us&edition=fundamental","pubTime":"2025-12-11 01:03","pubTimestamp":1765386224,"startTime":"0","endTime":"0","summary":"Legend Biotech's  share price weakness after the release of data from a phase 3 trial of a rival treatment for relapsed or refractory multiple myeloma is \"overdone\" as Legend's Carvykti can still be the preferred option, RBC Capital Markets said in a note emailed Wednesday.Johnson & Johnson's  teclistamab plus daratumumab therapy showed \"promising\" efficacy, the investment firm said.But Legend's Carvykti is still potentially the \"highest efficacy option, with one-and-done convenience, continued growth and penetration into early lines and the community setting,\" according to the note.The investment firm said it would be a buyer on Legend's weakness, and it expects near-term profitability for the company and further growth next year.RBC has an outperform rating on Legend stock and $74 price target.Price: 23.47, Change: -0.41, Percent Change: -1.73","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU1914381329.SGD","BK4505","IE0034235303.USD","IE000M9KFDE8.USD","IE00B2B36J28.USD","LU0234570918.USD","LU1032955483.USD","BK4585","BK4568","LU0640476718.USD","LU2089984988.USD","BK4550","IE00BLSP4239.USD","LU1244550577.SGD","LU2430703178.SGD","IE00BZ1G4Q59.USD","LU0912757837.SGD","IE00BSNM7G36.USD","IE00BN8TJ469.HKD","BK4559","LU2505996509.AUD","LU1023059063.AUD","LU1894683348.USD","LU2471134952.CNY","IE00BLSP4452.SGD","IE00B3PB1722.GBP","IE00B4R5TH58.HKD","IE00BFTCPJ56.SGD","IE00BKVL7J92.USD","LU0070217475.USD","LU0289739699.SGD","LU0345770308.USD","LEGN","LU2133065610.SGD","IE00B42XCP33.USD","LU1280957306.USD","BK4581","LU1732799900.SGD","BK4504","LU2602419157.SGD","LU0345770993.USD","IE00BGHQF631.EUR","LU1718418525.SGD","LU2112291526.USD","LU2430703251.USD","LU2471134879.HKD","LU2505996681.GBP","BK4139","JNJ","IE0002141913.USD"],"gpt_icon":0},{"id":"2590739329","title":"Cancer Study Buoys These Small Biotechs -- Barrons.com","url":"https://stock-news.laohu8.com/highlight/detail?id=2590739329","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590739329?lang=en_us&edition=fundamental","pubTime":"2025-12-10 04:31","pubTimestamp":1765312260,"startTime":"0","endTime":"0","summary":"The effectiveness of a leukemia drug from Terns Pharmaceuticals exceeded the hopes of many doctors and investors when the biotech firm reported early phase trial results this week.Terns shares jumped as much as 50% on the news that cancer cell counts fell over 99% in nearly three-fourths of the 38 leukemia patients treated for six months with the firm's once-daily pill. That's nearly twice the effectiveness of Scemblix, a similar drug from Novartis that has reached annual sales of a billion dollars.Arcellx was another stock lifted by study results reported at the American Society of Hematology meeting in Orlando, Fla. The shares popped 13% as a pivotal trial of its multiple-myeloma cell therapy showed fewer side effects with comparable efficacy to an established therapy from Legend Biotech. Shares of Legend slipped more than 10%.In about a hundred patients whose cancers advanced despite three or more other treatments, the Arcellx CAR-T eliminated measurable cancers in about three-quart","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BJT1NW94.SGD","LU2505996509.AUD","IE00B3T34201.USD","LU1935042991.SGD","BK4588","LU0985320562.USD","LU1261432733.SGD","IE00B1BXHZ80.USD","BK4505","BK4532","IE000M9KFDE8.USD","IE00B19Z3581.USD","LEGN","LU0889566641.SGD","SG9999002224.SGD","LU1032466523.USD","IE00B19Z3B42.SGD","IE00BBT3K403.USD","LU0203345920.USD","ACLX","LU2471134523.USD","LU2089984988.USD","LU1074936037.SGD","NVS","IE00BZ1G4Q59.USD","IE00BJJMRZ35.SGD","LU2129689605.HKD","LU1066051225.USD","LU1914381329.SGD","IE0002270589.USD","LU2750360641.GBP","JNJ","BK4568","LU1496350502.SGD","BK4585","IE00B2B36J28.USD","LU2468319806.SGD","IE00BFXG1179.USD","LU0640476718.USD","BK4581","IE00BVYPNW00.USD","LU0345770993.USD","LU1066051498.USD","LU1929549753.HKD","LU2430703251.USD","LU0058720904.USD","BK4578","CAR","IE00BSNM7G36.USD","LU2471134796.USD"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.legendbiotech.com","stockEarnings":[{"period":"1week","weight":0.0377},{"period":"1month","weight":0.0684},{"period":"3month","weight":-0.2706},{"period":"6month","weight":-0.4703},{"period":"1year","weight":-0.2829},{"period":"ytd","weight":0.0773}],"compareEarnings":[{"period":"1week","weight":-0.0233},{"period":"1month","weight":-0.0044},{"period":"3month","weight":0.0146},{"period":"6month","weight":0.068},{"period":"1year","weight":0.1339},{"period":"ytd","weight":-0.0064}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Legend Biotech Corp is a global, clinical-stage biopharmaceutical company engaged in the discovery and development of novel cell therapies for oncology and other indications. The company's differentiated technology, global development and manufacturing strategy and expertise provide it with the ability to generate, test and manufacture next-generation cell therapies targeting indications with high unmet needs.","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":-0.002161},{"month":2,"riseRate":0.4,"avgChangeRate":0.004169},{"month":3,"riseRate":0.4,"avgChangeRate":-0.028053},{"month":4,"riseRate":0.8,"avgChangeRate":0.075373},{"month":5,"riseRate":0.4,"avgChangeRate":0.007649},{"month":6,"riseRate":1,"avgChangeRate":0.150366},{"month":7,"riseRate":0.666667,"avgChangeRate":0.033873},{"month":8,"riseRate":0.166667,"avgChangeRate":-0.05555},{"month":9,"riseRate":0.166667,"avgChangeRate":-0.023313},{"month":10,"riseRate":0.333333,"avgChangeRate":-0.000245},{"month":11,"riseRate":0.333333,"avgChangeRate":-0.020911},{"month":12,"riseRate":0,"avgChangeRate":-0.105244}],"exchange":"NASDAQ","name":"Legend Biotech","nameEN":"Legend Biotech"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.0","shortVersion":"4.36.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Legend Biotech(LEGN),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Legend Biotech(LEGN) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Legend Biotech,LEGN,Legend Biotech股票,Legend Biotech股票老虎,Legend Biotech股票老虎国际,Legend Biotech行情,Legend Biotech股票行情,Legend Biotech股价,Legend Biotech股市,Legend Biotech股票价格,Legend Biotech股票交易,Legend Biotech股票购买,Legend Biotech股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Legend Biotech(LEGN),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Legend Biotech(LEGN) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}